Real‐world effectiveness of highly purified cannabidiol in epilepsy associated with 15q11.2‐q13.1 duplication and deletion syndromes: A multicenter study

Abstract This multicenter retrospective study evaluated the effectiveness and safety of highly purified cannabidiol (CBD) in 22 patients with 15q11.2‐q13.1 duplication or deletion syndromes (15q‐DDS), including 12 with 15q duplication syndrome (dup15q) and 10 with Angelman syndrome (AS). Median (int...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Emanuele Cerulli Irelli, Adolfo Mazzeo, Marco Perulli, Georgia Ramantani, Domenica Battaglia, Irene Bagnasco, Erica Cognolato, Pasquale Striano, Susanna Negrin, Alberto Danieli, Paolo Bonanni, Francesca F. Operto, Carlo Di Bonaventura, Antonietta Coppola, Alessandro Orsini
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2026-06-01
Ráidu:	Epilepsia Open
Fáttát:	Angelman syndrome CBD developmental and epileptic encephalopathy dup15q syndrome intellectual disability Lennox–Gastaut
Liŋkkat:	https://doi.org/10.1002/epi4.70241
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!